Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3433-3440
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3433
Table 1 The “drug-resistance” genes containing the promoter CpG island
GenesLocation relative to transcription start siteGenesLocation relative to transcription start site
ABCC4-487 to +466GSTP1-391 to +91
ABCC1-356 to +406hMLH1-72 to +393
ABCC13+138 to +386KIAA1337-553 to +413
ABCC3-96 to +358MAPK14-371 to +319
ABCB11+1 255 to +1 565OCLN-9 to +967
ABCC5-219 to +87POLB-209 to +34
ABCC6-229 to +89RAF1-466 to +399
ABCC8-185 to +531RALBP1-901 to +325
ABCG2-741 to -17RRM2-718 to +426
ATF2-418 to +545SKP2-663 to +182
B2M-170 to +83SLC19A1-719 to +268
BCAR3-328 to +126SLC22A1L-265 to +158
BCL2-7 to +573SPF45-547 to +92
BIRC4-527 to -235SRI-251 to +257
CAT+35 to +395SSA2-195 to +152
CFTR-515 to -55TOP2A-123 to +506
DCK-267 to +155TOP2B-805 to +393
ERBB2+173 to +534TP53+130 to +337
Table 2 The “drug resistance” genes in this study
Resistance mechanismGenes and ref.Function
Plasma membraneABCG2Belongs to the abc transporter family, appears to play a major role in the multidrug resistance
transporters/pumpphenotype of MCF-7 breast cancer cell line. When over-expressed, the transfected cells become
decrease or increase toresistant to mitoxantrone, daunorubicin and doxorubicin, display diminished intracellular
concentrationaccumulation reduce intracellular drug of daunorubicin, and manifest an
ATP-dependent increase in the efflux of rhodamine
CFTRBelongs to the abc transporter family. MRP subfamily, involved in the transport of chloride ions
RALBP1Activates specifically hydrolysis of GTP bound to RAC1 and CDC42. Mediates ATP-dependent
transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin(DOX) and is the major
ATP-dependent transporter of glutathioneconjugates of electrophiles (GS-E) and DOX in
erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may
contribute to the multidrug resistance phenomenon
Transcription factorATF2Belongs to the bZIP family, ATF subfamily, binding the cAMP response element (CRE)
and/or tumor suppressor(consensus sequence: 5’GTGACGT(A/C)(A/G)-3') as a transcription activator
TP53Acts as a tumor suppressor in many tumor types, involved in cell cycle regulation
as a transcription activator that acts to negatively regulate cell division by controlling
a set of genes required for this process
The enzymes involved inCATBelonging to the catalase family ,serves to protect cells from the toxic effects of
drug activation or inactivationhydrogen peroxide
metabolism abnormalityGSTP1Belongs to the GST superfamily. Pi family; Conjugation of reduced glutathione to
a wide number of exogenous and endogenous hydrophobic electrophiles
TOP2BControl of topological states of DNA by ATP-dependent breakage, passage and
rejoining of double-stranded DNA
DCKRequired for the phosphorylation of several deoxyribonucleosides and certain
nucleoside analogs widely employed as antiviral and chemotherapeutic agents
Cell signaling alteration andRAF1Belongs to the Ser/Thr family of protein kinases. RAF subfamily. Involved in
cell cycle checkpoints alterationthe transduction of mitogenic signals from the cell membrane to the nucleus as a
part of the Ras-dependent signaling pathway from receptors to the nucleus
SKP2Involved in regulation of G1/S transition as substrate recognition component of the
SCF (SKP1-CUL1-F- box protein) E3 ubiquitin ligase complex which mediates the
ubiquitination and subsequent proteasomal degradation of target proteins involved in
cell cycle progression, signal transduction and transcription
Unclear mechanismsB2MBeta-2-microglobulin is the beta-chain of major histocompatibility complex class I
molecules, Containing 1 immunoglobulin-like domain
OCLNMay play a role in the formation and regulation of the tight junction (TJ)
paracellular permeability barrier
SPF45Involved in nuclear mRNA splicing, via spliceosome
Table 3 The primers for MSP analysis
GenBank No.Gene symbolSense 5’-3’Antisense 5’-3’PositionSize(bp)
NT_016354ABCG2mTGTCGCGTTGAGTCGTTAAACGTCCCCGATACTTCG-698 to -464235
UTGTGTTTTGTTGTGTTGAGTTGTTCACTCTAATTCATTCCATTCAATC-591 to -457135
NT_005403ATF2mGGGTCGGAATAACGAACGATCACCTCGAATACTCCTAACG230 to 375146
UGGAGGGGTTGGAATAATGAATCCCATTTCCCATCACCTCAA220 to 379160
NT_010194B2MmATTTGGTATTGCGTCGTTGACGAAACGAAACATCTCGAC-128 to 23151
UTTTTTAATTTGGTATTGTGTTGTTGAACTCACACTAAATAACCTCCAAAC-134 to 83217
NT_009237CATmAGTAGCGGGTCGCGTAGAACCACCCGAACCTATCG118 to 372255
UGGAAGGAGTAGTGGGTTGTGTAACCACCCAAACCTATCACA112 to 372261
NT_007933CFTRmAGAGGTCGCGATTGTCGTTCGACTTTCTCCACCCACTACG-316 to -114203
UTTAAAGAGAGGTTGTGATTGTTGTTTCCTTCACTCCCTCACCA-322 to -174149
NT_006216DCKmTATACGCGCGGTTTCGTCGCCGACGAATATCGAA-168 to 27195
UTTTTTTGTTATATGTGTGGTTTTGTTACCCCTCAACCCTCACC-176 to -75102
NT_078018OCLNmTGCGTTCGTTAGGTGAGCCGAATCCCAACTCGAAAACG538 to 753216
UGTTAGGTGTGTTTGTTAGGTGAGTCACACCTCTCTAATTCCCACA532 to 772241
NT_022517RAF1mTCGGTCGTTTTGGAAGTCCCCTAAAACGCGAAACG-72 to 180252
UGGTTTGGTTGTTTTGGAAGTTCACCAAATATAACCACCTCCCACT-2 to 183185
NT_010859RALBP1mGGGTAAGTCGTTCGTTTTCGCCTCTCCGCTCAAACGACT-495 to -215281
UGTTAGTATTATATTGGGGTAAGTTGTTTGCCCTTCATCCCCAAACTCA-510 to -371140
NT_006576SKP2mGTCGTAGCGTCGTTCGTTCTACAACCCGCTCTACTTCG-198 to 10208
UTTTTTTAGTTAGTTGTAGTGTTGTTTGTTACCCACTCTACTTCACAACCAC-209 to 5214
NT_077569SPF45mAGTGTCGTTCGGTTTCGTTCCTCGAAAACTCCGACTACG-216 to -6211
UGTGGAGTGTTGTTTGGTTTTGTAACTTACATCTAACACCTCCCAAA-220 to -67154
NT_022517TOP2BmTGGGTTTCGTCGTTTCGTCCGCGCTAAACCCGAAC-241 to -66176
UGGTTGTTGGGTTTTGTTGTTTTTTCTCCTCAACCACCACACTAA-254 to -60195
NT_010718TP53mCGGAGTCGAGAGTTCGTGCCGAAAACACTTTACGTTCG157 to 279123
UGTTGAAAATATATGGAGTTGAGAGTTTCTTTCCACAACAATAACACACTTC190 to 291102
NT_033903GSTP1mGCGATTTCGGGGATTTTAACGACGACGAAACTCCAA-183 to 16199
UGTTGGGGATTTGGGAAAGTATAAAAATAATCCCACCCCACT-230 to -28203
Table 4 The early stage-specific change in methylation
GeneC/MN/MP
GSTpi24/3017/300.052
CFTR23/3016/300.058